Also, MEKi treatment was shown to partially or completely restore the suppressed production of IL-12 and TNF in DCs mediated by melanoma cells and reverse the melanoma-induced downregulation of costimulatory molecules and activation markers of DCs (14). This evidence concerns the gene TNF and melanoma.